A new trading day began on Tuesday, with Zoetis Inc (NYSE: ZTS) stock price down -1.15% from the previous day of trading, before settling in for the closing price of $166.32. ZTS’s price has ranged from $144.80 to $200.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 8.19%. Meanwhile, its annual earnings per share averaged 10.59%. With a float of $450.77 million, this company’s outstanding shares have now reached $451.55 million.
Considering the fact that the conglomerate employs 14100 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 68.87%, operating margin of 36.45%, and the pretax margin is 33.34%.
Zoetis Inc (ZTS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Zoetis Inc is 0.09%, while institutional ownership is 95.14%. The most recent insider transaction that took place on Nov 25 ’24, was worth 617,028. In this transaction Executive Vice President of this company sold 3,477 shares at a rate of $177.46, taking the stock ownership to the 3,249 shares. Before that another transaction happened on Nov 25 ’24, when Company’s Officer proposed sale 3,477 for $177.46, making the entire transaction worth $617,029.
Zoetis Inc (ZTS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.29% during the next five years compared to 11.57% growth over the previous five years of trading.
Zoetis Inc (NYSE: ZTS) Trading Performance Indicators
Here are Zoetis Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.10. Likewise, its price to free cash flow for the trailing twelve months is 32.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.32, a number that is poised to hit 1.38 in the next quarter and is forecasted to reach 6.37 in one year’s time.
Technical Analysis of Zoetis Inc (ZTS)
Compared to the last year’s volume of 2.64 million, its volume of 2.79 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 58.56%. Additionally, its Average True Range was 3.76.
During the past 100 days, Zoetis Inc’s (ZTS) raw stochastic average was set at 9.61%, which indicates a significant decrease from 54.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.11% in the past 14 days, which was lower than the 19.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $172.14, while its 200-day Moving Average is $176.03. Nevertheless, the first resistance level for the watch stands at $167.17 in the near term. At $169.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $172.73. If the price goes on to break the first support level at $161.61, it is likely to go to the next support level at $158.82. Now, if the price goes above the second support level, the third support stands at $156.05.
Zoetis Inc (NYSE: ZTS) Key Stats
With a market capitalization of 74.18 billion, the company has a total of 451,165K Shares Outstanding. Currently, annual sales are 8,544 M while annual income is 2,344 M. The company’s previous quarter sales were 2,388 M while its latest quarter income was 682,000 K.
